Although the exact mechanism of the decrease in survival rates of ERα-positive patients is unknown, one of the possible hormonal sources in HNSCC might be an estrogen production of inflammatory cells as a response to carcinogens, like it was previously described in lung cancer [94]. This evidence concerns the gene ESR1 and head and neck squamous cell carcinoma.